MedPath

logo therapy on leukemia patients

Phase 2
Conditions
leukaemia.
Plasma cell leukaemia, Myeloid leukaemia, Monocytic leukaemia , Other leukaemias of specified cell type , Leukaemia of unspecified cell type
C90.1, C92
Registration Number
IRCT2015050615590N3
Lead Sponsor
Vice chancellor for research,Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
16
Inclusion Criteria

Diagnosis of leukemia; Self awareness from cancer; high education in patients
Exclusion criteria: Have other disease (for example: other kind of cancer); Lack of knowledge regarding the disease; lack of inclination of patients for attending at intervention sessions

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Coping style with stress. Timepoint: Before treatment and 1 week after. Method of measurement: Coping Style Questionnaire.;Adaptation with illness. Timepoint: Before treatment and 1 week after. Method of measurement: Adaptation with Illness Questionnaire.;Life expectation. Timepoint: Before treatment and 1 week after. Method of measurement: Hope Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath